Contact:

Sam Lee
Director, Life Sciences and Health Care
1 416 673 6677

Toronto Region has specific R&D strengths in Biomarkers

Specialized Labour 

• $2.2 million J.C. Boileau Chair in Oncologic Pathology, Princess Margaret Hospital, University Health Network, Toronto
• $2.0 million Natural Sciences and Engineering Research Council (NSERC)/Medical Diagnostics Services (MDS) SCIEX Industrial Research Chair, York University
  
  

• Academic institutions
• Pharmaceutical and Biotechnology companies
• Joint government/industry consortia
  
  

Suppliers and Infrastructure

• Ontario Tumor Bank
• University Health Network Microarray Center
• Access to 13 million patient records database (Ontario eHealth strategy)
• Institute for Clinical Evaluative Studies (ICES)
• Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto
• Canadian Prostate Cancer BioResearch Network
• GeneNews - Biomarker diagnostics

 Public Sector R&D

• Ontario Cancer Biomarker Network (OCBN)
• The Centre for Applied Genomics (TCAG)
• McLaughlin Centre for Molecular Medicine, MaRS Centre, Toronto
• Ontario Institute of Cancer Research (OICR)
• Ontario Genomics Institute
• Biomarker research occurring at a network of hospitals and universities
  • University Health Network (Toronto General, Toronto Western and Princess Margaret hospitals)
  • Mt Sinai Hospital
  • Sick Kid's Hospital
  • Sunnybrook Health Sciences Centre
  • Queens University
  • University of Toronto
  • McMaster University
  • York University
  • Waterloo University